← 產業報告目錄
Lentiviral Vector (LVV) CDMO Services Market Size, Share & Trends Analysis Report By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 179報告編號 INSIGHTACE-5cc5b9321b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 9.0% is forecasted for the global Lentiviral Vector (LVV) CDMO Services Market over the assessment period of 2025 through 2034.
At its core, Lentiviral Vector (LVV) CDMO Services pertains to helpful for gene transfer in mammalian cells because they can efficiently transmit genes from one cell type to another. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Lentiviral Vector (LVV) CDMO Services Market Snapshot
Chapter 4. Global Lentiviral Vector (LVV) CDMO Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. IIT Grade
5.2.2. IND Grade
5.2.3. Clinical Trial Grade
5.2.4. Commercial Production Grade
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Biopharmaceutical Company
6.2.2. Academic Scientific Research Institution
Chapter 7. Lentiviral Vector (LVV) CDMO Services Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.1.2. North America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.1.3. North America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.2.2. Europe Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.2.3. Europe Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.3.2. Asia Pacific Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.3.3. Asia Pacific Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.4.2. Latin America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.4.3. Latin America Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
7.5.2. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.5.3. Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Thermo Fisher Scientific
8.2.2. GenScript ProBio
8.2.3. Hillgene
8.2.4. Charles River Laboratories
8.2.5. Ubrigene
8.2.6. Obio Technology (shanghai)
8.2.7. Genesail Biotech (Shanghai)
8.2.8. Wuxi Apptec
8.2.9. Porton Advanced Solutions
8.2.10. Pharmaron
8.2.11. Asymchem Laboratories (Tianjin), Merck
8.2.12. VectorBuilder
8.2.13. Yposkesi
8.2.14. Flash Therapeutics
8.2.15. VIVEBiotech
8.2.16. Miltenyi Bioindustry
8.2.17. Genezen
8.2.18. Miltenyi Biotec
8.2.19. Exthera
8.2.20. Catalent
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們